JP Morgan Chase’s Lineage Cell Therapeutics LCTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $16.1K | Buy |
10,944
+1,560
| +17% | +$2.63K | ﹤0.01% | 6615 |
|
|
2025
Q4 | $15.7K | Sell |
9,384
-3,985
| -30% | -$6.9K | ﹤0.01% | 6562 |
|
|
2025
Q3 | $22.6K | Sell |
13,369
-9,610
| -42% | -$11.4K | ﹤0.01% | 6450 |
|
|
2025
Q2 | $20.9K | Sell |
22,979
-582,065
| -96% | -$345K | ﹤0.01% | 6163 |
|
|
2025
Q1 | $273K | Sell |
605,044
-341,355
| -36% | -$200K | ﹤0.01% | 5104 |
|
|
2024
Q4 | $476K | Buy |
946,399
+269,237
| +40% | +$198K | ﹤0.01% | 5070 |
|
|
2024
Q3 | $613K | Buy |
677,162
+82,864
| +14% | +$76.8K | ﹤0.01% | 4772 |
|
|
2024
Q2 | $593K | Sell |
594,298
-81,406
| -12% | -$89.9K | ﹤0.01% | 4590 |
|
|
2024
Q1 | $1M | Sell |
675,704
-51,309
| -7% | -$58.2K | ﹤0.01% | 4346 |
|
|
2023
Q4 | $792K | Buy |
727,013
+17,535
| +2% | +$19.2K | ﹤0.01% | 4500 |
|
|
2023
Q3 | $837K | Sell |
709,478
-331,009
| -32% | -$450K | ﹤0.01% | 4175 |
|
|
2023
Q2 | $1.47M | Sell |
1,040,487
-71,624
| -6% | -$99K | ﹤0.01% | 3775 |
|
|
2023
Q1 | $1.67M | Buy |
1,112,111
+23,532
| +2% | +$32.8K | ﹤0.01% | 3667 |
|
|
2022
Q4 | $1.27M | Buy |
1,088,579
+39,528
| +4% | +$49.8K | ﹤0.01% | 3886 |
|
|
2022
Q3 | $1.19M | Sell |
1,049,051
-207,881
| -17% | -$305K | ﹤0.01% | 3872 |
|
|
2022
Q2 | $1.99M | Sell |
1,256,932
-592,730
| -32% | -$782K | ﹤0.01% | 3551 |
|
|
2022
Q1 | $2.85M | Buy |
1,849,662
+566,385
| +44% | +$879K | ﹤0.01% | 3478 |
|
|
2021
Q4 | $3.15M | Sell |
1,283,277
-932,515
| -42% | -$2.18M | ﹤0.01% | 3447 |
|
|
2021
Q3 | $5.58M | Buy |
2,215,792
+263,684
| +14% | +$677K | ﹤0.01% | 2943 |
|
|
2021
Q2 | $5.56M | Buy |
1,952,108
+1,952,035
| +2,674,021% | +$5.05M | ﹤0.01% | 2957 |
|
|
2021
Q1 | $0 | Sell |
73
-2,189
| -97% | -$5.26K | ﹤0.01% | 6213 |
|
|
2020
Q4 | $4K | Sell |
2,262
-10,282
| -82% | -$14.4K | ﹤0.01% | 5470 |
|
|
2020
Q3 | $12K | Buy |
12,544
+7,008
| +127% | +$6.19K | ﹤0.01% | 5236 |
|
|
2020
Q2 | $5K | Sell |
5,536
-173,310
| -97% | -$153K | ﹤0.01% | 5185 |
|
|
2020
Q1 | $148K | Buy |
178,846
+37,000
| +26% | +$36.8K | ﹤0.01% | 4387 |
|
|
2019
Q4 | $127K | Buy |
141,846
+106,390
| +300% | +$88.6K | ﹤0.01% | 4822 |
|
|
2019
Q3 | $35K | Buy |
35,456
+5,751
| +19% | +$5.96K | ﹤0.01% | 5281 |
|
|
2019
Q2 | $31K | Buy |
29,705
+2,170
| +8% | +$2.5K | ﹤0.01% | 5347 |
|
|
2019
Q1 | $36K | Sell |
27,535
-13,466
| -33% | -$16.7K | ﹤0.01% | 5241 |
|
|
2018
Q4 | $38K | Buy |
41,001
+17,294
| +73% | +$26.5K | ﹤0.01% | 5171 |
|
|
2018
Q3 | $49K | Buy |
23,707
+2,922
| +14% | +$6.14K | ﹤0.01% | 5201 |
|
|
2018
Q2 | $37K | Buy |
20,785
+855
| +4% | +$1.72K | ﹤0.01% | 5173 |
|
|
2018
Q1 | $47K | Sell |
19,930
-61,916
| -76% | -$145K | ﹤0.01% | 4837 |
|
|
2017
Q4 | $154K | Buy |
+81,846
| New | +$179K | ﹤0.01% | 4516 |
|
|
2016
Q3 | – | Sell |
-2,270
| Closed | -$5K | – | 4685 |
|
|
2016
Q2 | $5K | Hold |
2,270
| – | – | ﹤0.01% | 4452 |
|
|
2016
Q1 | $6K | Sell |
2,270
-1,219
| -35% | -$2.72K | ﹤0.01% | 4336 |
|
|
2015
Q4 | $12K | Buy |
+3,489
| New | +$10.4K | ﹤0.01% | 4175 |
|
|
2013
Q4 | – | Sell |
-13,495
| Closed | -$41K | – | 4172 |
|
|
2013
Q3 | $41K | Buy |
+13,495
| New | +$42.7K | ﹤0.01% | 4279 |
|
Other funds holding LCTX
BC
VCM
DC
RA
AC
